OH2 Oncolytic Viral Therapy in Central Nervous System Tumors
Clinical trial NCT05235074 · COMPLETED
Trial details
- NCT number
- NCT05235074
- Sponsor
- Binhui Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2026-07-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.